Northwest Biotherapeutics, Inc. financial reports, Northwest Biotherapeutics, Inc. annual revenue in 2024. When does Northwest Biotherapeutics, Inc. report revenue?
Northwest Biotherapeutics, Inc. total revenue, net income and dynamics of changes in Euro today
Northwest Biotherapeutics, Inc. net income is now -4 123 000 €. The dynamics of net income of Northwest Biotherapeutics, Inc. has changed by 276 176 000 € in recent years. Here are the main financial indicators of Northwest Biotherapeutics, Inc.. Northwest Biotherapeutics, Inc. online financial report chart. The financial graph of Northwest Biotherapeutics, Inc. displays the online status: net income, net revenue, total assets. The financial report chart on our website displays information by dates from 31/03/2019 to 31/03/2021.
Report date
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
31/03/2021
223 061.81 €
-29.499 % ↓
-3 848 049.50 €
-
31/12/2020
469 456.44 €
-43.924 % ↓
-261 606 700.59 €
-4300.49453 % ↓
30/09/2020
201 595.61 €
-63.575 % ↓
-181 152 320.05 €
-
30/06/2020
1 866.63 €
-99.656 % ↓
-54 087 354.98 €
-26562.1 % ↓
31/12/2019
837 181.76 €
-
6 227 997.65 €
-
30/09/2019
553 454.61 €
-
-5 825 739.75 €
-
30/06/2019
542 254.85 €
-
204 395.55 €
-
31/03/2019
316 393.11 €
-
-19 549 174.10 €
-
Show:
to
Northwest Biotherapeutics, Inc. financial report charts
The dates of the latest financial statements of Northwest Biotherapeutics, Inc.: 31/03/2019, 31/12/2020, 31/03/2021. The dates of financial statements are strictly regulated by law and financial statements. The current date of the financial report of Northwest Biotherapeutics, Inc. for today is 31/03/2021. Gross profit Northwest Biotherapeutics, Inc. is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit Northwest Biotherapeutics, Inc. is -6 684 000 €
Northwest Biotherapeutics, Inc. quarterly report dates
Cost of revenue Northwest Biotherapeutics, Inc. is the total cost of producing and distributing of products and services of a company. Cost of revenue Northwest Biotherapeutics, Inc. is 6 923 000 € Total revenue Northwest Biotherapeutics, Inc. refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue Northwest Biotherapeutics, Inc. is 239 000 € Operating income Northwest Biotherapeutics, Inc. is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Northwest Biotherapeutics, Inc. is -19 570 000 €
Net income Northwest Biotherapeutics, Inc. is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Northwest Biotherapeutics, Inc. is -4 123 000 € Current assets Northwest Biotherapeutics, Inc. is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Northwest Biotherapeutics, Inc. is 13 217 000 € Total assets Northwest Biotherapeutics, Inc. refers to the total amount of assets owned by a person or entity. Total assets Northwest Biotherapeutics, Inc. is 32 460 000 €
31/03/2021
31/12/2020
30/09/2020
30/06/2020
31/12/2019
30/09/2019
30/06/2019
31/03/2019
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
-6 238 264.09 €
-7 837 029.26 €
-16 280 711.97 €
-2 910 069.93 €
-2 789 672.56 €
-2 628 209.41 €
-2 529 278.23 €
-2 487 279.15 €
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
6 461 325.90 €
8 306 485.70 €
16 482 307.58 €
2 911 936.56 €
3 626 854.32 €
3 181 664.02 €
3 071 533.08 €
2 803 672.25 €
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
223 061.81 €
469 456.44 €
201 595.61 €
1 866.63 €
837 181.76 €
553 454.61 €
542 254.85 €
316 393.11 €
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
-
-
-
-
-
-
-
-
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
-18 264 935.41 €
6 944 782.03 €
-44 684 226.50 €
-6 940 115.47 €
-6 163 599.05 €
-6 025 468.73 €
-6 194 398.38 €
-7 248 108.76 €
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
-3 848 049.50 €
-261 606 700.59 €
-181 152 320.05 €
-54 087 354.98 €
6 227 997.65 €
-5 825 739.75 €
204 395.55 €
-19 549 174.10 €
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
-
-
-
-
-
-
-
2 803 672.25 €
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
18 487 997.22 €
-6 475 325.59 €
44 885 822.11 €
6 941 982.09 €
7 000 780.81 €
6 578 923.34 €
6 736 653.23 €
7 564 501.87 €
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
12 335 597.92 €
14 476 617.94 €
11 370 552.28 €
7 669 032.92 €
2 986 601.60 €
4 267 107.04 €
8 312 085.58 €
17 341 888.85 €
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
30 295 339.98 €
30 705 064.39 €
25 398 246.67 €
13 911 963.58 €
8 520 214.38 €
9 468 460.39 €
13 723 434.35 €
22 838 169.11 €
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
6 969 981.48 €
9 317 263.68 €
8 633 145.25 €
5 557 878.92 €
347 192.44 €
1 838 626.61 €
6 230 797.59 €
15 201 802.14 €
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
-
-
-
-
38 446 895.72 €
49 860 380.40 €
51 765 272.23 €
69 266 757.61 €
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
-
-
-
-
-
-
-
-
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
-
-
-
-
49 181 861.85 €
60 366 684.84 €
63 195 556.54 €
77 433 246.36 €
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
-
-
-
-
577.24 %
637.56 %
460.49 %
339.05 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
-329 646 151.60 €
-338 744 086.72 €
-198 261 813.96 €
-75 894 213.22 €
-40 661 647.47 €
-50 898 224.46 €
-49 472 122.19 €
-54 595 077.25 €
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
-
-
-
-
-5 579 345.11 €
-6 021 735.48 €
-9 032 603.21 €
-9 100 735.06 €
Last revenue report of Northwest Biotherapeutics, Inc. was 31/03/2021. According to last financial report total revenue in Northwest Biotherapeutics, Inc. was 223 061.81 Euro and changed by -29.499% since last year. Net income in Northwest Biotherapeutics, Inc. was -3 848 049.50 € in last quartal, net income changes to -4300.49453%.
Current cash Northwest Biotherapeutics, Inc. - the sum of all of the cash a company has on the date of report. Current cash Northwest Biotherapeutics, Inc. is 7 468 000 €
Northwest Biotherapeutics, Inc. stocks data
NBYB.SG stock price
Northwest Biotherapeutics, Inc. stock price today, NBYB.SG stock quote.
